A Study of Intravitreal Injections of 2.0mg Ranibizumab in Subjects With Chronic Fluid On OCT Post Multiple Injections With Ranibizumab (Super-dose Anti-VEgf SAVE Trial)
Clinical trial NCT01025232 · TERMINATED
Trial details
- NCT number
- NCT01025232
- Sponsor
- David M. Brown, M.D.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-01-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.